Because liposarcoma is rare, commonly recurs, and has evolving treatments, it cannot be overemphasized that patients should be referred to specialized cancer treatment centers where a larger ...

Patients with unresectable, metastatic liposarcoma or leiomyosarcoma are the focus of this open-label, single-arm expansion cohort. The combination therapy will be administered in standard 21-day ...

Background Liposarcoma (LS) is the second-most common type of soft-tissue sarcoma. Despite advances in knowledge and treatment of this disease, there remains a need for more effective LS therapy.